Ocular presentations of breast cancer

Acta Ophthalmologica Scandinavica

Volumn 85, Issue 2, 2007, Pages 133-142

  Wickremasinghe, Sanj ^a   Dansingani, Kunal K ^a   Tranos, Paris ^a   Liyanage, Sidath ^a   Jones, Alison ^a   Davey, Clare ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Choroid; Ciliary body; Complications; Eye; Iris; Ophthalmic manifestations; Opticnerve; Retina; Toxicity; Uvea

Indexed keywords

ANASTROZOLE; ANTINEOPLASTIC AGENT; ARTIFICIAL TEAR; CAPECITABINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; EXEMESTANE; FLUOROURACIL; LETROZOLE; MEDROXYPROGESTERONE ACETATE; MEGESTROL; METHOTREXATE; NAVELBINE; PACLITAXEL; STEROID; TAMOXIFEN; TRASTUZUMAB;

ADJUVANT THERAPY; ALOPECIA; BLEPHARITIS; BLURRED VISION; BRAIN METASTASIS; BREAST CANCER; BREAST SURGERY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CATARACT; CHOROID CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONJUNCTIVITIS; CORNEA DISEASE; DRUG WITHDRAWAL; DRY EYE; EUROPE; EXTERNAL BEAM RADIOTHERAPY; EYE CANCER; EYE DISEASE; EYE IRRITATION; EYE PAIN; GLAUCOMA; GYNECOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; INTRAOCULAR HYPERTENSION; KERATOPATHY; LACRIMATION DISORDER; LASER COAGULATION; LASER SURGERY; LOW DRUG DOSE; MEDICAL SPECIALIST; METASTASIS POTENTIAL; NORTH AMERICA; OPTIC NEURITIS; ORBIT METASTASIS; PARANEOPLASTIC SYNDROME; PHOTOPHOBIA; PRIORITY JOURNAL; RETINA MACULOPATHY; RETINOPATHY; REVIEW; SCOTOMA; SEXUAL DYSFUNCTION; SYMPTOM; VASOMOTOR DISORDER;

BREAST NEOPLASMS; CILIARY BODY; FEMALE; HUMANS; RETINAL NEOPLASMS; UVEAL NEOPLASMS;

EID: 33846954397     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2006.00737.x     Document Type: Review

References (117)

1. d'Abbadie I, Arriagada R, Spielmann M & Le MG (2003): Choroid metastases: Clinical features and treatments in 123 patients. Cancer 98: 1232-1238.
2. Aharon-Peretz J & Feinsod M (1994): [Visual hemineglect as presenting symptom of right parietal tumours.] Harefuah 126: 56.
3. Albert DM, Zimmermann AW Jr & Zeidman I (1967): Tumour metastasis to the eye. 3. The fate of circulating tumour cells to the eye. Am J Ophthalmol 63: 733-738.
4. Al-Tweigeri T, Magliocco AM & DeCoteau JF (1999): Cortical blindness as a manifestation of hypomagnesaemia secondary to cisplatin therapy: case report and review of literature. Gynecol Oncol 72: 120-122.
5. Amer R, Pe'er J, Chowers I & Anteby I (2004): Treatment options in the management of choroidal metastases. Ophthalmologica 218: 372-377.
6. Amoaku WM & Archer DB (1990a): Fluorescein angiographic features, natural course and treatment of radiation retinopathy. Eye 4: 657-667.
7. Amoaku WM & Archer DB (1990b): Cephalic radiation and retinal vasculopathy. Eye 4: 195-203.
8. Barishak YR, Baruh E & Lazar M (1978): Metastatic tumour of the iris: Case report. Ann Ophthalmol 10: 1191-1193.
9. Baum M, Budzar AU, Cuzick J et al. (2002): Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomized trial. Lancet 359: 2131-2139.
10. Beck M & Mills PV (1979): Ocular assessment of patients treated with tamoxifen. Cancer Treat Report 63: 1833-1834.
11. Bentley CR, Davies G & Aclimandos WA (1992): Tamoxifen retinopathy: a rare but serious complication. BMJ 304: 495-496.
12. Blum R (1975): An overview of studies with adriamycin in the United States. Cancer Chemother Report 6: 247-251.
13. Bonadonna G, Brusamolino E, Valagussa P et al. (1976): Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Medical 19: 405-410.
14. Brinkley JR Jr (1980): Response of a choroidal metastasis to multiple-drug chemotherapy. Cancer 45: 1538-1539.
15. Brown GC, Shields JA, Sanborn G, Augsburger JJ, Schatz NJ & Savino PJ (1981): Radiation retinopathy. Trans Pa Acad Ophthalmol Otolaryngol 34: 144-151.
16. Budde-Steffen C, Anderson NE, Rosenblum MK et al. (1988): An antineuronal autoantibody in paraneoplastic opsoclonus. Ann Neurol 23: 528-531.
17. Bullock JD & Yanes B (1980): Ophthalmic manifestations of metastatic breast cancer. Ophthalmology 87: 961-973.
18. Caravella LP Jr, Burns JA & Zangmeister M (1981): Punctal-canalicular stenosis related to systemic fluorouracil therapy. Arch Ophthalmol 99: 284-286.
19. Chen YR, Lin TH, Chan SM et al. (1998): Bilateral choroidal metastases as the initial presentation of a small breast carcinoma: A case report. Zhonghua Yi Xue Za Zhi (Taipei) 61: 99-103.
20. Chiang MF, Brock M & Patt S (1990): Pituitary metastases. Neurochirurgia (Stuttg) 33: 127-131.
21. Clark JH, Peck EJ Jr & Anderson JN (1974): Oestrogen receptors and antagonism of steroid hormone action. Nature 251: 446-448.
22. Cohen VM, Moosavi R & Hungerford JL (2005): Tamoxifen-induced regression of a choroidal metastasis in a man. Arch Ophthalmol 123: 1153-1154.
23. Day R, Ganz PA, Costantino JP, Cronin WM, Wickerham DL & Fisher B (1999): Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Clin Oncol 17: 2659-2669.
24. Demirci H, Shields CL, Chao AN & Shields JA (2003): Uveal metastasis from breast cancer in 264 patients. Am J Ophthalmol 136: 264-271.
25. Dieing A, Schulz CO, Schmid P et al. (2004): Orbital metastases in breast cancer: Report of two cases and review of the literature. J Cancer Res Clin Oncol 130: 745-748.
26. Doroshow JH, Locker GY, Gaasterland DE, Hubbard SP, Young RC & Myers CE (1981): Ocular irritation from high-dose methotrexate therapy: pharmacokinetics of drug in the tear film. Cancer 48: 2158-2162.
27. Early Breast Cancer Trialist Collaborative Group (2000): Early Breast Cancer Trialist Collaborative Group Meeting, Oxford, September 2000.
28. Escudero D, Barnadas A, Codina M, Fueyo J & Graus F (1993): Anti-Ri-associated paraneoplastic neurologic disorder without opsoclonus in a patient with breast cancer. Neurology 43: 1605-1606.
29. Eskridge JB (1993): Extraocular motor dysfunction associated with tumours. Optom Clin 3: 135-160.
30. Esmaeli B, Burnstine MA, Ahmadi MA & Prieto VG (2003): Docetaxel-induced histologic changes in the lacrimal sac and the nasal mucosa. Ophthal Plast Reconstr Surg 19: 305-308.
31. Esmaeli B & Hortobagyi GN (2001): Canalicular stenosis as the underlying mechanism for epiphora in patients receiving weekly docetaxel. Oncologist 6: 551-552.
32. Esmaeli B, Valero V, Ahmadi MA & Booser D (2001): Canalicular stenosis secondary to docetaxel (taxotere): A newly recognized side effect. Ophthalmology 108: 994-995.
33. Esteva FJ, Valero V, Pusztai L, Boehnke-Michaud L, Buzdar AU & Hortobagyi GN (2001): Chemotherapy oW metastatic breast cancer: what to expect in 2001 and beyond. Oncologist 6: 133-146.
34. Ferry AP (1967): Metastatic carcinoma of the eye and ocular adnexa. Int Ophthalmol Clin 7: 615-658.
35. Ferry AP & Font RL (1974): Carcinoma metastatic to the eye and orbit. I. A clinicopathologic study of 227 cases. Arch Ophthalmol 92: 276-286.
36. Flaxel CJ, Mulholland B, Haynes B & Gregor ZJ (2000): Intraocular penetration of tamoxifen. Ophthalmology 107: 2006-2009.
37. Font RL & Ferry AP (1976): Carcinoma metastatic to the eye and orbit. III. A clinicopathologic study of 28 cases metastatic to the orbit. Cancer 38: 1326-1335.
38. Fraunfelder FT & Meyer SM (1983): Ocular toxicity of antineoplastic agents. Ophthalmology 90: 1-3.
39. Gerner EW (1989): Ocular toxicity of tamoxifen. Ann Ophthalmol 21: 420-423.
40. Gorin MB, Day R, Costantino JP et al. (1998): Longterm tamoxifen citrate use and potential ocular toxicity. Am J Ophthalmol 125: 493-501.
41. Green GJ & Lessell S (1977): Acquired cerebral dyschromatopsia. Arch Ophthalmol 95: 121-128.
42. Griffin JD & Garnick MB (1981): Eye toxicity of cancer chemotherapy: a review of the literature. Cancer 48: 1539-1549.
43. Griffiths MF (1987): Tamoxifen retinopathy at low dosage. Am J Ophthalmol 104: 185-186.
44. Hall GH, Proctor EA & Taylor PC (1972): Cataracts after renal transplantation. Br Med J 19: 469.
45. Hamersley J, Luce JK, Florentz TR, Burkholder MM & Pepper JJ (1973): Excessive lacrimation from fluorouracil treatment. JAMA 225: 747-748.
46. Heier JS, Dragoo RA, Enzenauer RW & Waterhouse WJ (1994): Screening for ocular toxicity in asymptomatic patients treated with tamoxifen. Am J Ophthalmol 117: 772-775.
47. Henderson JW (1973): Orbital Tumours. Philadelphia: WB Saunders, 474-491.
48. Hodgson NC, Button JH, Franceschi D, Moffat FL & Livingstone AS (2004): Male bIeast cancer: is the incidence increasing? Ann Surg Oncol 11: 751-755.
49. Hofstra LS, de Vries EG & Willemse PH (1997): Ophthalmic toxicity following paclitaxel infusion. Ann Oncol 8: 1053.
50. Horner F (1864): Carcinoma der dura mater exophthalmus. Klin Monatsbl Augenheilkd 2: 186-190.
51. Hortobagyi GN (1998): Treatment of breast cancer. N Engl J Med 339: 974-984.
52. Hortobagyi G (2000): Adjuvant therapy for breast cancer. Annu Rev Med 51: 377-392.
53. Hortobagyi GN & Buzdar AU (1995): Current status of adjuvant systemic therapy for primary breast cancer: Progress and controversy. CA Cancer J Clin 45: 199-226.
54. Howell A, Cuzick J, Baum M et al. (2005): Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) Trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365: 60-62.
55. Huober J, Holz FG, Schmid H et al. (1997): [Paraneoplastic retinopathy in two patients with breast carcinoma.] Zentralbl Gynakol 119: 278-281.
56. Imperia PS, Lazarus HM & Lass JH (1989): Ocular complications of systemic cancer chemotherapy. Surv Ophthalmol 34: 209-230.
57. Jack MK & Hicks JD (1981): Ocular complications in high-dose chemoradiotherapy and marrow transplantation. Ann Ophthalmol 13: 709-711.
58. Jacobson DM (1996): Paraneoplastic disorders of neuro-ophthalmologic interest. Curr Opin Ophthalmol 7: 30-38.
59. Johnson DR & Burns RP (1965): Blepharoconjunctivitis associated with cancer chemotherapy. Trans Pacific Coast Otoophthalmol Soc Annu Meet 46: 43-49.
60. Kaiser-Kupfer MI, Kupfer C & Rodrigues MM (1981): Tamoxifen retinopathy. A clinicopathologic report. Ophthalmology 88: 89-93.
61. Kaiser-Kupfer MI & Lippman ME (1978): Tamoxifen retinopathy. Cancer Treat Report 62: 315-320.
62. Kende G, Sirkin SR, Thomas PR & Freeman AI (1979): Blurring of vision: A previously undescribed complication of cyclophosphamide therapy. Cancer 44: 69-71.
63. Kidmas AT, Ugwu BT, Manasseh AN, Iya D & Opaluwa AS (2005): Male breast malignancy in Jos University Teaching Hospital. West Afr J Med 24: 36-40.
64. Kreusel KM, Wiegel T, Stange M, Bornfeld N & Foerster MH (2000): [Intraocular metastases of metastatic breast carcinoma in the woman. Incidence, risk factors and therapy.] Ophthalmologe 97: 342-346.
65. Leititis JU, Burghard R, Rietschel E, Rieger CH & Brandis M (1985): Stevens-Johnson syndrome during an immunosuppressive therapy with cyclophosphamide and prednisone. Klin Padiatr 197: 441-442.
66. Lieb WE, Shields JA, Shields CL & Spaeth GL (1990): Mucinous adenocarcinoma metastatic to the iris, ciliary body and choroid. Br J Ophthalmol 74: 373-376.
67. Lorenzo Bermejo J & Hemminki K (2005): A population-based assessment of the clustering of breast cancer in families eligible for testing of BRCA1 and BRCA2 mutations. Ann Oncol 16: 322-329.
68. Mamounas EP (2000): Antiaromatase agents after adjuvant tamoxifen: rationale and clinical implications. Clin Breast Cancer 1 (Suppl 1): 22-27.
69. Manquez ME, Shields CL, Karatza EC & Shields JA (2005): Regression of choroidal metastases from breast carcinoma using aromatase inhibitors. Br J Ophthalmol 89: 776-777.
70. Massot-Punyet R, Almajano J & Camacho JM (2000): [Cerebral metastasis.] Rev Neurol 31: 1242-1247.
71. Matsui Y, Mehta MC, Katsumi O, Brodie SE & Hirose T (1992): Electrophysiological findings in paraneoplastic retinopathy. Graefes Arch Clin Exp Ophthalmol 230: 324-328.
72. McCartney A (1993): Intraocular metastasis. Br J Ophthalmol 77: 133.
73. Mejia-Novelo A, Varado-Miranda A, Morales-Vazquez F et al. (2004): Ocular metastases from breast carcinoma. Med Oncol 21: 217-221.
74. Mewis L & Young SE (1982): Breast carcinoma metastatic to the choroid. Analysis of 67 patients. Ophthalmology 89: 147-151.
75. Nayfield SG & Gorin MB (1996): Tamoxifen-associated eye disease. A review. J Clin Oncol 14: 1018-1026.
76. Nelson CC, Hertzberg BS & Klintworth GK (1983): A histopathologic study of 716 unselected eyes in patients with cancer at the time of death. Am J Ophthalmol 95: 788-793.
77. Noureddin BN, Seoud M, Bashshur Z, Salem Z, Shamseddin A & Khalil A (1999): Ocular toxicity in low-doAe tamoxifen: a prospective study. Eye 13: 729-733.
78. O'Brien J, Wieland M & Filer R (2000): Breast cancer metastatic to the choroid in a male patient. Retina 20: 214-216.
79. O'Gorman CS, Awad ZT & Given HF (2001): Bilateral choroidal metastases as the initial presentation of breast carcinoma. Ir Med J 94: 85-86.
80. Office of National Statistics (2002): Registrations of Cancer Diagnosed in 1998, England. (Report no. MB1 29). London: The Stationery Office.
81. Ohguro H, Takaya T, Ogawa K, Suzuki J & Nakagawa T (1997): [Cancer-associated retinopathy.] Nippon Ganka Gakkai Zasshi 101: 283-287.
82. Ohmer R, Golnik KC, Richards AI & Kosmorsky GS (1999): Ophthalmoplegia associated with the anti-Ri antibody. J Neuroophthalmol 19: 246-248.
83. Pavlidis NA, Petris C, Briassoulis E et al. (1992): Clear evidence that longterm, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients. Cancer 69: 2961-2964.
84. Perl M (1872): Contributions to ocular pathology of tumours. Virchows Archiv A 56: 445-448.
85. Polans AS, Witkowska D, Haley TL, Amundson D, Baizer L & Adamus G (1995): Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumour of a patient with cancer-associated retinopathy. Proc Natl Acad Sci U S A 92: 9176-9180.
86. Pugesgaard T & von Eyben FE (1986): Bilateral optic neuritis evolved during tamoxifen treatment. Cancer 58: 383-386.
87. Quinn AG & Clemett RS (1993): Retinopathy after low-dose retinal irradiation. Aust N Z J Ophthalmol 21: 193-197.
88. Rudoler SB, Corn BW, Shields CL et al. (1997): External beam irradiation for choroid metastases: Identification of factors predisposing to longterm sequelae. Int J Radiat Oncol Biol Phys 38: 251-256.
89. Sasco AJ (2001): EpidemioAogy of breast cancer: an environmental disease? APMIS 109: 321-332.
90. 2. J Clin Oncol 12: 1741-1742.
91. Shams'ili S, Grefkens J, de Leeuw B et al. (2003): Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 126: 1409-1418.
92. Shapiro MS, Thoft RA, Friend J, Parrish RK & Gressel MG (1985): 5-fluorouracil toxicity to the ocular surface epithelium. Invest Ophthalmol Vis Sci 26: 580-583.
93. Shields CL, Shields JA, de Potter P et al. (1997b): Plaque radiotherapy for the management of uveal metastasis. Arch Ophthalmol 115: 203-209.
94. Shields CL, Shields JA, Gross NE, Schwartz GP & Lally SE (1997a): Survey of 520 eyes with uveal metastases. Ophthalmology 104: 1265-1276.
95. Shields JA & Shields CL (1992): Metastatic tumours to the intraocular structures. In: Shields JA & Shields CL (eds). Intraocular Tumours. Philadelphia: Saunders 207-238.
96. Shields JA, Shields CL, Kiratli H & de Potter P (1995): Metastatic tumours to the iris in 40 patients. Am J Ophthalmol 119: 422-430.
97. Shields JA, Shields CL & Singh AD (2000): Metastatic neoplasms in the optic disc: The 1999 Bjerrum Lecture. Part 2. Arch Ophthalmol 118: 217-224. xx
98. Silvestris N, Di CS, Ferretti G et al. (2003): Breast cancer metastatic to the choroid in a male patient: Case report. Tumori 89: 333-335.
99. Straus DJ, Mausolf FA, Ellerby RA & McCracken JD (1977): Cicatricial ectropion secondary to 5-fluorouracil therapy. Med Oncol 3: 15-19.
100. Tamura M, Tada T, Tsuji H et al. (2004): Clinical study on the metastasis to the eyes from breast cancer. Breast Cancer 11: 65-68.
101. Therssen R, Jansen E, Leys A, Rutten J & Meyskens J (1995): Screening for tamoxifen ocular toxicity: A prospective study. Eur J Ophthalmol 5: 230-234.
102. Toler SM (2004): Oxidative stress plays an important role in the pathogenesis of drug-induced retinopathy. Exp Biol Med (Maywood) 229: 607-615.
103. van der Heijden A, Twijnstra A, Lamers WP, Hupperets PS & Freling G (1991): An unusual cause of diplopia in a cancer patient. Eur J Cancer 27: 1315-1316.
104. Viebahn M & Barracks ME (1993): Potentiating effect of diabetes in radiation retinopathy. Int J Radiat Oncol Biol Phys 25: 379-380.
105. Viebahn M, Barricks ME & Osterloh MD (1991): Synergism between diabetic and radiation retinopathy: Case report and review. Br J Ophthalmol 75: 629-632.
106. Volpe NJ & Albert DM (1994): Metastases to the uvea. In: Albert DM & Jakobiec FA (eds). Principles and Practice of Ophthalmology. Philadelphia: WB Saunders 3260-3270.
107. Weiss L (1992): Comments on haematogenous metastatic patterns in humans as revealed by autopsy. Clin Exp Metastasis 10: 191-199.
108. Weiss R, Grisold W, Jellinger K, Muhlbauer J, Scheiner W & Vesely M (1984): Metastasis of solid tumours in extraocular muscles. Acta Neuropathol (Berl) 65: 168-171.
109. Weiss AJ, Jackson LG & Carabasi R (1961): An evaluation of 5-fluorouracil in malignant disease. Ann Intern Med 55: 731-741.
110. Weiss HD, Walker MD & Wiernik PH (1974): Neurotoxicity of commonly used antineoplastic agents (first of two parts). N Engl J Medical 291: 75-81.
111. Wiegel T, Bottke D, Kreusel KM et al. (2002): External beam radiotherapy of choroidal metastases - final results of a prospective study of the German Cancer Society (ARO 95-08). Radiother Oncol 64: 13-18.
112. Wiegel T, Kreusel KM, Bornfeld N et al. (1998): Frequency of asymptomatic choroidal metastasis in patients with disseminated breast cancer: Results of a prospective screening programme. Br J Ophthalmol 82: 1159-1161.
113. Williams NJ, Leris AC, Kouriefs C, Mokbel KM, Hungerford J & Carpenter R (2000): Choroidal metastasis - the initial presentation of breast carcinoma. Eur J Surg Oncol 26: 817-818.
114. Wirtz PW, Sillevis Smitt PA, Hoff JI et al. (2002): Anti-Ri antibody positive opsoclonus-myoclonus in a male patient with breast carcinoma. J Neurol 249: 1710-1712.
115. Woog JJ, Chess J, Albert DM, Dueker DK, Berson FG & Craft J (1984): Metastatic carcinoma of the iris simulating iridocyclitis. Br J Ophthalmol 68: 167-173.
116. Yeo JH, Jakobiec FA, Iwamoto T, Brown R & Harrison W (1983): Metastatic carcinoma masquerading as scleritis. Ophthalmology 90: 184-194.
117. Zhang GJ, Adachi I, Yin DF et al. (1995): Eyelid metastasis from breast cancer showing marked response to chemotherapy. Jpn J Clin Oncol 25: 10-15.